supported by the National Science and Technology Major Project(2019ZX09732001,China);the National Basic Research Program of China(2015CB553701,China)
Meplazumab is an anti-CD147 humanized IgG2 antibody.The purpose of this study was to characterize the nonclinical safety,tolerance and efficacy evaluation of meplazumab treating chloroquine resistant Plasmodium falcip...
ACKNOWLEDGEMENTS This work was supported in part by grants from the National Basic Research Program of China (2009CB522306 and 2012CBA01305), the National Natural Science Foundation of China (30872317, 30800113, U0832601 and 81172876), the Knowledge Innovation Program of CAS (KSCX1-YW-10 and KSCX2-EW-R-13), the Key Scientific and Technological Program of China (2009ZX09501-029, 2012ZX10001-006 and 2012ZX10001-007) and Yunnan province (2010GA001) and the 'Western Light' Projects of the CAS. The funding organizations had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
It is currently widely accepted that immune activation in HIV-infected individuals leads to a severe loss of CD4+ T cells and the progression to AIDS. However, the underlying mechanism of this immune activation remai...